Search

Search Constraints

You searched for: Author/Creator Chatterjee, Arkendu

Search Results

2. Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study. Issue 6 (June 2021)

3. Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study. (May 2022)

4. Pembrolizumab in relapsed or refractory Richter syndrome. (16th June 2020)